Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-29 · accession 0001193125-25-336619 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-29 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $34.38 | -85 | 50.5K | -0.2% | -$2,922 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-29 | S | D | 85 | $34.38 | 50,450 | D | — | — | (F2) Includes 293 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2025. (F3) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |